Menchinelli, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 3.533
AS - Asia 1.815
EU - Europa 1.761
SA - Sud America 398
AF - Africa 75
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.596
Nazione #
US - Stati Uniti d'America 3.391
SG - Singapore 820
IT - Italia 521
CN - Cina 350
BR - Brasile 322
SE - Svezia 310
VN - Vietnam 234
DE - Germania 197
FR - Francia 157
PL - Polonia 119
GB - Regno Unito 104
CA - Canada 80
IE - Irlanda 79
FI - Finlandia 65
IN - India 64
ID - Indonesia 59
AT - Austria 44
JP - Giappone 43
BD - Bangladesh 41
TR - Turchia 40
RU - Federazione Russa 39
HK - Hong Kong 38
AR - Argentina 31
MX - Messico 28
NL - Olanda 27
ZA - Sudafrica 25
MA - Marocco 23
CH - Svizzera 20
UA - Ucraina 18
KR - Corea 17
ES - Italia 16
IQ - Iraq 16
PH - Filippine 15
SA - Arabia Saudita 15
EC - Ecuador 14
PK - Pakistan 12
BE - Belgio 10
IR - Iran 9
AU - Australia 8
CL - Cile 8
CZ - Repubblica Ceca 8
LT - Lituania 8
PY - Paraguay 8
UZ - Uzbekistan 8
JO - Giordania 7
TT - Trinidad e Tobago 7
CI - Costa d'Avorio 6
CO - Colombia 6
JM - Giamaica 6
BS - Bahamas 5
KE - Kenya 5
KZ - Kazakistan 5
VE - Venezuela 5
DO - Repubblica Dominicana 4
IL - Israele 4
AZ - Azerbaigian 3
BG - Bulgaria 3
ET - Etiopia 3
LB - Libano 3
NP - Nepal 3
PA - Panama 3
UY - Uruguay 3
VA - Santa Sede (Città del Vaticano) 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
BB - Barbados 2
BZ - Belize 2
DZ - Algeria 2
EG - Egitto 2
EU - Europa 2
HN - Honduras 2
LK - Sri Lanka 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
RO - Romania 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BO - Bolivia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
GR - Grecia 1
IM - Isola di Man 1
IS - Islanda 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MU - Mauritius 1
MY - Malesia 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SV - El Salvador 1
TW - Taiwan 1
UG - Uganda 1
Totale 7.596
Città #
Singapore 454
Ashburn 314
Chandler 293
San Jose 214
Chicago 149
New York 123
Warsaw 110
Rome 106
Ho Chi Minh City 85
Los Angeles 83
Beijing 77
Dublin 75
The Dalles 72
Fairfield 60
Milan 59
Wilmington 56
Ann Arbor 52
Council Bluffs 51
Cattolica 50
Hanoi 50
Jakarta 49
Munich 47
Lauterbourg 42
Tokyo 42
San Mateo 41
Houston 40
Hefei 38
Helsinki 37
North Bergen 34
Vienna 34
Woodbridge 32
Boston 31
Hong Kong 31
Princeton 31
São Paulo 31
Frankfurt am Main 30
Seattle 29
Denver 27
Dallas 26
Jacksonville 25
Moscow 24
Washington 24
Brooklyn 23
Philadelphia 23
Atlanta 22
Boardman 21
Cambridge 21
Nuremberg 21
Izmir 20
London 19
Marseille 19
Nanjing 19
Orem 19
Redwood City 19
Zurich 19
Montreal 18
Da Nang 16
Guangzhou 16
Phoenix 16
The Bronx 16
Johannesburg 15
Lappeenranta 15
Seoul 15
Chennai 14
Dearborn 14
Paris 14
Buffalo 13
Falls Church 13
Cleveland 12
Manchester 12
Stockholm 12
Bremen 11
Kent 11
Toronto 11
Brussels 10
Guarulhos 10
Las Vegas 10
Memphis 10
Mexico City 10
Newark 10
Rio de Janeiro 10
San Francisco 10
Santa Clara 10
Shanghai 10
Augusta 9
Hangzhou 9
Lancaster 9
Queens 9
Turku 9
Amsterdam 8
Belo Horizonte 8
Bexley 8
Florence 8
Poplar 8
Tashkent 8
Andover 7
Brno 7
Busto Arsizio 7
Düsseldorf 7
Kish 7
Totale 4.035
Nome #
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli 837
In vitro Evaluation of BACT/ALERT® VIRTUO®, BACT/ALERT 3D®, and BACTEC™ FX Automated Blood Culture Systems for Detection of Microbial Pathogens Using Simulated Human Blood Samples 340
Optimized Use of the MALDI BioTyper System and FilmArray BCID Panel for the Direct Identification of Microbial Pathogens from Positive Blood Cultures 249
Antimicrobial susceptibility testing of pathogens isolated from blood culture: a performance comparison of Accelerate Pheno (TM) and VITEK (R) 2 systems with the broth microdilution method 221
Development of a Multiplex PCR Platform for the Rapid Detection of Bacteria, Antibiotic Resistance, and Candida in Human Blood Samples 204
Comparison of Mycoplasma IES, Mycofast Revolution and Mycoplasma IST2 to detect genital mycoplasmas in clinical samples. 204
Rapid molecular tests for detection of antimicrobial resistance determinants in Gram-negative organisms from positive blood cultures: a systematic review and meta-analysis 193
Assessment of SARS-CoV-2 RNA Test Results among Patients Who Recovered from COVID-19 with Prior Negative Results 190
Direct use of eazyplex® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections 189
Diagnosis and Treatment of Bacterial Pneumonia in Critically Ill Patients with COVID-19 Using a Multiplex PCR Assay: A Large Italian Hospital’s Five-Month Experience 188
Efficient Recovery of Candida auris and Five Other Medically Important Candida Species from Blood Cultures Containing Clinically Relevant Concentrations of Antifungal Agents 186
Different detection capabilities by mycological media for Candida isolates from mono- or dual-species cultures 179
Evaluating the newly developed BioFire COVID-19 test for SARS-CoV-2 molecular detection 173
Simulated Pediatric Blood Cultures to Assess the Inactivation of Clinically Relevant Antimicrobial Drug Concentrations in Resin-Containing Bottles 166
A Laboratory-Developed Assay for the Simultaneous Detection of Aspergillus fumigatus and Pneumocystis jirovecii Pulmonary Pathogens 162
Early assessment of blood culture negativity as a potential support tool for antimicrobial stewardship 158
3-(Benzodioxan-2-ylmethoxy)-2,6-difluorobenzamides bearing hydrophobic substituents at the 7-position of the benzodioxane nucleus potently inhibit methicillin-resistant Sa and Mtb cell division 158
T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood 157
Pilot study on cultural and metagenomic analysis of bile and biliary stents lead to unveiling the key players in stent occlusion 154
Comparing BioFire FilmArray BCID2 and BCID panels for direct detection of bacterial pathogens and antimicrobial resistance genes from positive blood cultures 152
Risk Factors for Mortality in Adult COVID-19 Patients Who Develop Bloodstream Infections Mostly Caused by Antimicrobial-Resistant Organisms: Analysis at a Large Teaching Hospital in Italy 139
Re-evaluating positive serum samples for SARS-CoV-2-specific IgA and IgG antibodies using an in-house serological assay 138
EUCAST rapid antimicrobial susceptibility testing of blood cultures positive for Escherichia coli or Klebsiella pneumoniae: experience of three laboratories in Italy 137
Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007–2015) 136
Simplified Testing Method for Direct Detection of Carbapenemase-Producing Organisms from Positive Blood Cultures Using the NG-Test Carba 5 Assay 136
Verification of the Vitek Reveal System for Direct Antimicrobial Susceptibility Testing in Gram-Negative Positive Blood Cultures 131
Implementation of the eazyplex(®) CSF direct panel assay for rapid laboratory diagnosis of bacterial meningitis: 32-month experience at a tertiary care university hospital 130
Lumipulse G SARS-CoV-2 Ag assay evaluation using clinical samples from different testing groups 127
SARS-CoV-2 Antigen Test Results to Infer Active or Non-Active Virus Replication Status in COVID-19 Patients 124
Chip-Based Molecular Evaluation of a DNA Extraction Protocol for Candida Species from Positive Blood Cultures 124
A new pcr‐based assay for testing bronchoalveolar lavage fluid samples from patients with suspected pneumocystis jirovecii pneumonia 122
Direct testing for kpc-mediated carbapenem resistance from blood samples using a t2 magnetic resonance based assay 121
Sars-cov-2 antigen detection to expand testing capacity for covid-19: Results from a hospital emergency department testing site 120
Evaluation of three commercial assays for SARS-CoV-2 molecular detection in upper respiratory tract samples 119
Susceptibility of Meropenem-Resistant and/or Carbapenemase-Producing Clinical Isolates of Enterobacterales (Enterobacteriaceae) and Pseudomonas aeruginosa to Ceftazidime-Avibactam and Ceftolozane-Tazobactam as Assessed by In Vitro Testing Methods 115
First case of bacteremic liver abscess caused by an ST260-related (ST1861), hypervirulent Klebsiella pneumoniae 113
New Data on the in Vitro Activity of Fenticonazole against Fluconazole-Resistant Candida Species 111
Cutaneous diphtheria most likely due to exposure in a detention camp in Libya 107
Setting-specific variability of false-positive result rates with rapid testing for SARS-CoV-2 antigen 105
Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples 104
Resistance and virulence features of hypermucoviscous Klebsiella pneumoniae from bloodstream infections: Results of a nationwide Italian surveillance study 97
Fish-derived antimicrobial peptides: Activity of a chionodracine mutant against bacterial models and human bacterial pathogens 97
Sources and Transmission Routes of Carbapenem-Resistant Pseudomonas aeruginosa: Study Design and Methodology of the SAMPAN Study 96
Optimized Use of the MALDI BioTyper System and the FilmArray BCID Panel for Direct Identification of Microbial Pathogens from Positive Blood Cultures 93
Efficient Inactivation of Clinically Relevant Antimicrobial Drug Concentrations by BacT/Alert or Bactec Resin-Containing Media in Simulated Adult Blood Cultures 89
Saliva is a valid alternative to nasopharyngeal swab in chemiluminescence-based assay for detection of sars-cov-2 antigen 83
First bloodstream infection caused by Prevotella copri in a heart failure elderly patient with Prevotella-dominated gut microbiota: a case report 82
Design and characterization of chionodracine-derived antimicrobial peptides with enhanced activity against drug-resistant human pathogens 76
T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood 75
Improving the diagnosis of central nervous system infections: experience with the off-label use of FA-BCID2 7
Improving time-to-result: head-to-head comparison of three rapid AST systems for Gram-negative bacteremia, including the newly developed VITEK REVEAL 3
Totale 7.717
Categoria #
all - tutte 27.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.981


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 0 0 0 17
2021/2022444 35 9 20 46 13 31 7 68 34 35 85 61
2022/2023971 128 108 51 130 46 109 32 61 91 123 53 39
2023/2024586 39 108 24 48 40 101 51 21 15 29 34 76
2024/20251.102 19 24 79 44 72 38 50 41 170 112 234 219
2025/20263.761 374 85 201 437 494 142 494 135 261 190 866 82
Totale 7.717